Cargando…
Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry
Reflecting on the WHO consultation on developing global norms for sharing data and results during public health emergencies, Patrick Vallance and colleagues argue that there are significant benefits to the principle of data sharing.
Autores principales: | Vallance, Patrick, Freeman, Andrew, Stewart, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701406/ https://www.ncbi.nlm.nih.gov/pubmed/26731493 http://dx.doi.org/10.1371/journal.pmed.1001936 |
Ejemplares similares
-
The evolving role of investigative toxicology in the pharmaceutical industry
por: Pognan, Francois, et al.
Publicado: (2023) -
How Basic Scientists Help the Pharmaceutical Industry Market Drugs
por: Fugh-Berman, Adriane
Publicado: (2013) -
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
por: Hopkins, Ashley M., et al.
Publicado: (2018) -
Dilemmas about instructions for administering drugs and indications for their use: is there negative effect of pharmaceutical industry?
por: Zerem, Enver
Publicado: (2020) -
The Elements of Data Sharing
por: Zhang, Zhang, et al.
Publicado: (2020)